Corrections
Mirtazapine added to SSRIs or SNRIs for treatment resistant depression in primary care: phase III randomised placebo controlled trial (MIR)
BMJ 2018; 363 doi: https://doi.org/10.1136/bmj.k4691 (Published 15 November 2018) Cite this as: BMJ 2018;363:k4691
An acknowledgement was missed off this paper (BMJ 2018;363:k4218, doi:10.1136/bmj.k4218) by Kessler and colleagues. The authors would like to state that: This study was designed and delivered in collaboration with the Bristol Randomised Trials Collaboration, a UK Clinical Research Collaboration registered clinical trials unit which, as part of the Bristol Trials Centre, is in receipt of support funding from the National Institute for Health Research Clinical Trials Unit.